This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
A slow but sure approach to governance can keep AI champions focused on improving patient care when—and even after—the technology builds unstoppable momentum seemingly of its own accord.
Peter Weiss, MD, a veteran electrophysiologist, sat down with Cardiovascular Business to discuss the ongoing rise of pulsed field ablation. While he's impressed with the technology, he says many questions remain about its long-term value.
The FDA has finalized new Class I recalls related to ongoing safety concerns with Boston Scientific’s Accolade family of pacemakers. A software update is now available to help address the issue, and an additional update is already in the works.
What good is AI in healthcare if it doesn’t improve financial margins? The question is getting posed in the C-suites of provider organizations and insurance companies.
Is U.S. healthcare capable of achieving its own quadruple aim? Or is that ideal destined to remain a perpetual pursuit, always chased but never really caught?
Tracking private equity acquisitions can be challenging, but that didn't stop researchers from exploring the last decade of activity in cardiology. "It will be critical to monitor the effects on procedural utilization, quality and outcomes for patients with CVD,” the group wrote.
The U.S. is far from alone in the world in its wranglings across public and private sectors to adopt propitious healthcare AI innovations quickly yet safely.
Abbott has received multiple reports of its HeartMate monitor screens freezing, glitching and even displaying incorrect patient information. A total of 17 injuries have been reported so far.